CNBC Exclusive: Eisai U.S. CEO on Alzheimer's drug approval

CNBC's Meg Tirrell talks to Ivan Cheung, Eisai U.S. CEO on the company's Alzheimer's drug receiving approval from the FDA today. With CNBC's Tyler Mathisen and the Fast Money traders, Tim Seymour, Bonawyn Eison, Steve Grasso and Jeff Mills.

By: CNBC Television
Title: CNBC Exclusive: Eisai U.S. CEO on Alzheimer's drug approval
Sourced From: www.youtube.com/watch?v=yZKR29LTkhw

News.... browse around here

F1!! 

Stroll wife

Trading News: https://www.bitcoinisle.com/2022/03/01/2-key-derivatives-metrics-signal-bitcoin-traders-expect-btc-to-hold-40000/

Exciting Finds: Zet news roundup

Stay up to date on China: https://www.chinapulse.com/data-news/2021/01/13/chinese-face-recognition-unicorn-megvii-prepares-for-ipo-in-china-techcrunch/

https://www.nucondo.ca/amfvp/when-is-seabrook-nuclear-plant-closing.html
Did you miss our previous article...
https://newshub247.com/cnbc/jim-cramer-reminds-investors-that-market-pain-is-needed-to-prevent-endless-price-hikes